Invitae Appoints William H. Osborne to its Board of Directors

– Brings invaluable expertise in leading, operating and scaling global businesses throughout his career in aerospace, transportation and integrated solutions – SAN FRANCISCO, Jan. 30, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, has announced that...

Click to view original post